Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment

By Harrold John   Abraham Anson  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 41, Iss. 2, 2014-04 ,pp. : 141-151

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modeling of Anesthetics in Children: Therapeutic Implications

By Mazoit Jean-Xavier  

Pediatric Drugs, Vol. 8, Iss. 3, 2006-01 ,pp. : 139-150

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins

By Mahmood Iftekhar   Green Martin D.  

Clinical Pharmacokinetics, Vol. 44, Iss. 4, 2005-01 ,pp. : 331-347

Adis International

Access to resources Recommend Favorite

A Pharmacokinetic–Pharmacodynamic Model of Chemotherapy of Human Immunodeficiency Virus Infection that Relates Development of Drug Resistance to Treatment Intensity

By Jackson Robert C.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 713-730

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

By Yang Bing-Bing   Lum Peggy   Chen Alin   Arends Rosalin   Roskos Lorin   Smith Brian   Ruixo Juan José Pérez  

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 729-740

Adis International

Access to resources Recommend Favorite